United States of America: Federal Trade Commission announced proposed settlement with NextMed over deceptive online advertising

On 14 July 2025, the Federal Trade Commission (FTC) announced a proposed settlement with telemedicine company NextMed over charges that it had used deceptive claims and fake reviews, and testimonials in advertising. NextMed disseminated advertisements using online banners, paid search advertisements, and social media advertisements on sites such as YouTube and Facebook. Under the terms of the consent order, NextMed would be prohibited from making misrepresentations about its telehealth services and pay USD 150'000 to the FTC, intended to provide customer refunds. The settlement remains subject to final approval by the FTC.